Clinical Trials
277 trialsARTIHCC
Humanitas Clinical and Research Center
BELLA
Peter MacCallum Cancer Centre, Australia
BORTEM-17
Haukeland University Hospital
Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids
Tongji Hospital
PREVENT-2
Guangxi Medical University
Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
Gruppo Italiano Malattie EMatologiche dell'Adulto
RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes
Peking University Third Hospital
Prolgo-HL
St. Petersburg State Pavlov Medical University
DLI-Boost
Assistance Publique - Hôpitaux de Paris
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
University of Kansas Medical Center
Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer
Nanfang Hospital, Southern Medical University
V-CHANCE
National Cancer Institute, Naples
Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum
South Valley University
DMIA
Vitadx
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
Nanfang Hospital, Southern Medical University
JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
Guangdong Second Provincial General Hospital
The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
Chongqing University Cancer Hospital
T1 Squamous Cell Carcinomas of the Lip
Maastricht University Medical Center
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Maastricht University Medical Center
Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis
China Medical University Hospital
Abdominal or Transanal TME for Rectal Cancer Therapy
Cantonal Hospital of St. Gallen
CRU3
University of Milano Bicocca
REDUCE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CORE1
Azienda Ospedaliera Universitaria Integrata Verona
Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients
The First Affiliated Hospital of Soochow University
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Zhongnan Hospital
Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Shanghai Zhongshan Hospital
TvT CAR7
Great Ormond Street Hospital for Children NHS Foundation Trust
TaRRGET
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
FLICOR
Imperial College London
GI-HPVT-01
BGI, China
DaRT-V
Cambridge University Hospitals NHS Foundation Trust
POTERE
University of Bologna
CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Decitabine and Anti-PD-1 in R/R DLBCL
Chinese PLA General Hospital
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
Ankara Training and Research Hospital
CILI
National Cancer Institute, Naples
RE-GEND
Kyorin University
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Chang Gung Memorial Hospital
Bio-NMDAr
Hospices Civils de Lyon
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
First Affiliated Hospital of Zhejiang University
Relyage
Centre Hospitalier Universitaire, Amiens
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
ERASE-pilot
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
CAR-NK Targeted CD19 for r/r B-cell Malignancies
Affiliated Hospital to Academy of Military Medical Sciences